Cell Therapy & Viral Vectors: Clinical-Grade Manufacturing in One Place
Driven By Purpose and Powered By Science
Why We Do It
We believe that life-saving therapies deserve the highest standards of care. At SCTbio, we’re inspired by the transformative power of cell and gene therapies. Driven by a biotech mindset, we understand your journey thanks to our history as clinical-stage developers. Our mission is to help researchers, biotech innovators, and healthcare systems bring these therapies to patients — safely, efficiently, and without compromise.
What We Do
We are a full-service European cell and gene therapy CDMO specializing in somatic and genetically modified cells, as well as viral vector solutions. From early development through GMP manufacturing and global logistics, we offer flexible, end-to-end solutions tailored to your needs. With nearly two decades of experience, we support both clinical and commercial projects with precision and care.
How We Do It
One team, start to finish — including QC — all under one roof, giving you full transparency and control. No hidden costs, no unexpected delays. You’ll work with a dedicated project manager as your single point of contact, backed by a GMP facility built to the highest international standards. Having managed Phase I–III clinical oncology programs across the EU, US, and China, we bring global scale and insight to ensure every process is data‑driven, compliant, and delivered with scientific rigor by a team genuinely invested in your success.
Why They Choose Us
Clients choose us because we think like developers, not just service providers. As former drug developers, we anticipate challenges, de‑risk programs, and go the extra mile, including early-stage development projects with universities. Our Prague HQ, strategically close to European clinical sites, combines a low‑cost, high‑efficiency base with robust in‑house QC and scalable GMP infrastructure to speed production. Backed by PPF Group’s financial stability and seamless transatlantic logistics, we offer technical agility and proven operational scale to deliver therapies faster.
Our Capabilities
Your high-quality and accessible CDMO
As a long-term manufacturing partner, we will strategically support your project across every step of the cell therapy manufacturing chain. We offer full services covering GMP production of Advanced Therapy Medicinal Products including lentiviral and gammaretroviral vectors. SCTbio leverages nearly two decades of experience in development of autologous cell-based products, product supply for clinical trials, GMP compliance for the full lifecycle of drug development, manufacturing, quality control, QP certification, storage, logistics and process development services to deliver the highest quality collaboration for your CDMO needs.
Our History
Nearly Two Decades of Innovation and Dedication in Cell and Gene Therapy Manufacturing
SCTbio was founded in 2021 as a spin-off from SOTIO, rooted on CAR-T and dendritic cell know-how, to meet the rising demand for cell and gene therapy manufacturing.
Building nearly two decades of expertise and over 2,000 GMP batches across advanced cell types, SCTbio combines deep scientific proficiency with a commitment to advancing next-generation therapies.
In 2024, SCTbio established its Boston office, marking a significant step toward global reach and closer collaboration with North American biotech innovators.
Measured in Results.
Proven in Impact.
~20
years
manufacturing cell & gene therapies
3
Qualified Persons on Site for agile batch release
150+
legacy EU/US qualified apheresis sites — unmatched expertise in clinical collection management
2,000+
GMP batches manufactured
2,000 m²
of advanced facilities, including 420 m² of Class A/B/C GMP cleanrooms
12,000
IMPs delivered worldwide
75+
cell therapy experts dedicated to your success
Our Team
Find out more about SCTbio — an experienced and reliable CDMO for cell and gene therapy services.
Jakub Čierný
Chief Quality Compliance Officer
Tomáš Fajnor
Chief Financial Officer
Klára Murcková
Production Manager
Susan Nichols
Fractional Chief Commercial Officer
Martin Pávek
Chief Operating Officer
Daniela Rožková
Chief Technology Officer
Aleš Slavíček
Head of GMP QA
Luděk Sojka
Chief Executive Officer
Our Trusted Network
By integrating our deep in-house expertise with a curated network of premier global collaborators, SCTbio provides a comprehensive one-stop-shop that simplifies your supply chain and accelerates your therapy’s path to the patient.
What Our Partners Say About Us
“Auditing SCTbio revealed to us a company in which GMP culture is deeply rooted, the quality system is well structured, and GMP readiness is not just a marketing keyword thanks to the constant effort of SCTbio’s people, their expertise, their commitment, and their attention to quality.”
Laporte Euro
“SCTbio stands out as a reliable partner for customized cryopreservation and logistic services. We were impressed by the experienced team's willingness to collaborate, helping accommodate our unique requirements with an impressive commitment to quality that ensures our leukopaks continue to meet the needs of our customers.”
Cyto-Care.eu GmbH
“SCTbio already had an impressive track record of experience with autologous cell therapy manufacturing, including not just GMP manufacturing and analytical capabilities, but a sophisticated cold chain operation, scheduling and supply chain software, and extensive network of qualified leukapheresis sites.”
SOTIO Biotech
